effective, the vaccine structure is also safe . Finally, we use in silico cloning to simulate vaccine large-scale production .
Universal CD20 CAR-γδ T cell therapy has been granted Fast Track designation by the US FDA. What are the advantages of γδ T cells?
Time of Update: 2022-06-12
April 21, 2022/eMedClub News/--On April 19, 2022, Adicet Bio announced that the U. S. FDA has granted its CD20-targeting allogeneic CAR-γδ T product candidate ADI-001 Fast Track designation
The overall design of the largest coal-to-olefin project with an investment of 67.4 billion yuan starts
Time of Update: 2022-06-10
in Tianchen Company. In this meeting, Tianchen Company, as the overall institute of the project, organized various installation institutes to discuss the follow-up work in detail and reached a consensus
Express AstraZeneca/Daiichi Sankyo's blockbuster ADC won the 5th breakthrough therapy designation for the treatment of HER2 low-expressing breast cancer
Time of Update: 2022-05-31
” Reference: [1] ENHERTU® Granted Breakthrough Therapy Designation in US for Patients with HER2 Low Metastatic Breast Cancer.
Fast delivery improves activity and durability, and a new generation of ready-to-use CAR-T therapy is granted orphan drug designation by the FDA
Time of Update: 2022-05-30
" Reference: Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR T Cell Product Candidate, for the Treatment of Multiple Myeloma.
Allogene Generic BCMA CAR-T Therapy Receives FDA Orphan Drug Designation
Time of Update: 2022-05-30
-killing activity compared to BCMA CAR-T cells from myeloma patients . Allogeneic strategies have become a major trend in allogeneic CAR-T therapy The product development time
FDA Breakthrough Therapy Designation for Pfizer's RSV Vaccine Protects the Elderly
Time of Update: 2022-05-26
References:[1] Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults.
Lihe Technology will invest 130 million yuan to obtain a 5% stake in Shanghai Survey and Design Research Institute
Time of Update: 2022-05-24
of the first (38 nationwide) national engineering research centers to be included in the new sequence management. It is a co-construction unit of the National Engineering Research Center for Greenhouse Gas Monitoring Technology and Equipment
CGF's golden design principles to drive the plastic packaging cycle
Time of Update: 2022-05-23
【Chemical Machinery Equipment Network Industry News】In cooperation with the Consumer Goods Forum, a cross-value chain organization of major brand owners, recyclers and plastics associations is developing a set of "golden design principles" for sustainable packaging design .
Junshi Bio's Toripalimab for the Treatment of Small Cell Lung Cancer Receives Orphan Drug Designation by the U.S. FDA
Time of Update: 2022-05-21
>will help toripalimab enjoy certain policy support in the follow-up research and development, registration and commercialization of toripalimab in the United States , including but not limited to (1) taxation
Junshi Bio's Toripalimab in the Treatment of Small Cell Lung Cancer Receives FDA Orphan Drug Designation
Time of Update: 2022-05-21
On April 13, Toripalimab, an anti-PD-1 monoclonal antibody independently developed by Junshi Bio for the treatment of small cell lung cancer (SCLC), was granted orphan drug designation by the U.
batch of green design demonstration enterprises for industrial products
Time of Update: 2022-05-20
> (5) It complies with the requirements of national and local laws, regulations and standards, and has not had any of the following situations in the past three years: major or above major production safety and quality accidents, grade
Connoya's Claudin 18.2 ADC Receives FDA Fast Track Designation for Gastric Cancer
Time of Update: 2022-05-19
Previously, Connoya has obtained FDA approval for CMG901 clinical trials in gastric cancer and gastroesophageal junction adenocarcinoma in the United States in March 2021, and received FDA orphan drug designation in April 2022 .
LANXESS provides design software for the food industry
Time of Update: 2022-05-18
The new module enables the dimensioning of ion exchange systems, including some unique process configurations that can only be achieved with the Lewatit type specially developed for food applications .
and Designated Medical Institutions for New Coronary Virus Infected Persons"
Time of Update: 2022-05-16
> Professor Lu Hongzhou took the initiative to provide it for everyone to download and use for free . >Professor
Xiao Yuxiu's group has made new progress in the rational design and application of dual-emitting lanthanide metal-organic frameworks
Time of Update: 2022-05-15
Recently, the Journal of Hazardous Materials (Journal of Hazardous Materials) published the latest progress made by Professor Xiao Yuxiu's group from the School of Pharmacy, Wuhan University in the rational design and application of dual-emitting lanthanide metal-organic frameworks.
Wood to provide designs for Total's massive green hydrogen project in Chile
Time of Update: 2022-05-15
Wood's research will provide Total Ellen and Magellan University with an accurate environmental impact assessment and risk analysis around the H₂ Magallanes project, in line with the high environmental and social standards set by the Chilean government .
Chinese Academy of Sciences scholars were invited to publish an important review of computational enzyme design in Trends magazine
Time of Update: 2022-05-15
After more than 4 billion years of evolution of life, the biochemical reactions catalyzed by enzymes constitute the core basis of life activities
A new generation of ready-to-use CAR-T therapy with improved activity and durability receives FDA orphan drug designation
Time of Update: 2022-05-14
"References:Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR T Cell Product Candidate, for the Treatment of Multiple Myeloma.
